Dismiss Notice
Join Physics Forums Today!
The friendliest, high quality science and math community on the planet! Everyone who loves science is here!

Stem Cell Research

  1. Sep 6, 2007 #1

    Astronuc

    User Avatar
    Staff Emeritus
    Science Advisor

    I heard an interview with Darwin Prockop from Tulane's Center for Gene Therapy. It was very interesting, especially the discussion about cells which function to repair damaged cells. The interview may be available next week. Meanwhile -
    Fascinating stuff!

    Faculty - http://www.genetherapy.tulane.edu/faculty.shtml [Broken]

    Prockop's CV - http://www.genetherapy.tulane.edu/pdf/DJP_CV_081505.pdf [Broken] (61 pages, over 500 publications!)
     
    Last edited by a moderator: May 3, 2017
  2. jcsd
  3. Sep 14, 2007 #2

    Astronuc

    User Avatar
    Staff Emeritus
    Science Advisor

    Stem Cells & Diabetes - Progress
    http://www.healthshow.org/archive/week_2007_09_02.shtml#2304 [Broken] (MP3 download of show available on page.

    Real Audio - http://healthshow.org/audio/1014/1014b.smil [Broken]

    Prockop talks about various types of stem cells. First discovered in the 1970's, they were recognized by different names: fibroblastoid colony forming units, marrow stromal cells (a hemotological name), mesenchymal stem cells, and now multi-potent stromal cells. Embryonic stem cells are easy to differentiate into different cell types, which makes them so attractive.

    Stromal cell form the basis of potential new therapies, e.g. -
    Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
     
    Last edited by a moderator: May 3, 2017
  4. Sep 24, 2007 #3
    Thanks for those links Astronuc they are quite interesting. I'll have to take a closer look at them when I get home tonight. The one about stem cells and diabetes sounds promising, it will be cool to see how far they get with that.
     
Share this great discussion with others via Reddit, Google+, Twitter, or Facebook